Avenir Corp Novavax Inc Transaction History

Avenir Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$6.67 - $9.52 $1,000 - $1,428	-150 Reduced 0.52%	28,460 $211,000
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $120,983 - $262,129	-21,004 Reduced 42.33%	28,610 $198,000
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $6 Million - $12.8 Million	49,614 New	49,614 $10.5 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Avenir Corp, based on Form 13F filings with the SEC.

Stay updated on Avenir Corp with notifications on news.